These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5400760)

  • 21. [Therapeutic results in lung diseases caused by atypical mycobacteria].
    Fischer P; Schilling W
    Z Erkr Atmungsorgane; 1984; 162(1):26-9. PubMed ID: 6202070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Symposium: chemotherapy including new antitubercular agents].
    Fukuhara T; Yoshida F; Sasaoka A; Mitsui M
    Kekkaku; 1971 Feb; 46(2):3-4. PubMed ID: 5549795
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of urogenital tuberculosis. Urological aspects].
    Tümmers H; Brühl P
    Fortschr Med; 1974 Jan; 92(3):101-7. PubMed ID: 4131872
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prophylactic and preventive measures in the fight against tuberculosis].
    Simon K
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 137(2):151-8. PubMed ID: 5748058
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative studies on various antituberculosis chemotherapies--from the results of the Tuberculosis Research Committee (Ryoken).
    Gomi J
    Jpn J Tuberc; 1966 Dec; 13():96-105. PubMed ID: 4166383
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of infection due to "atypical" mycobacteria.
    Johnston RN
    Tubercle; 1969 Mar; 50():Suppl:88-92. PubMed ID: 4319136
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comments on the current state of experimental chemotherapy of tuberculosis].
    Urbancík R; Markovic J
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):169-73. PubMed ID: 4971152
    [No Abstract]   [Full Text] [Related]  

  • 28. [Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
    Janowiec M; Andrzejczyk Z; Szwedowicz I
    Pneumonol Pol; 1988 Jun; 56(6):278-82. PubMed ID: 3226945
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo].
    Ota Y
    Kekkaku; 1971 Dec; 46(12):493-500. PubMed ID: 5004603
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
    Kuze F
    Am Rev Respir Dis; 1984 Mar; 129(3):453-9. PubMed ID: 6703503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 32. [Principles of rational tuberculosis chemotherapy].
    Khomenko AG
    Antibiotiki; 1980 Jul; 25(7):534-9. PubMed ID: 7406466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium xenopi and mycobacteriosis. A clinical bacteriologic report.
    Elston HR; Duffy JP
    Am Rev Respir Dis; 1973 Oct; 108(4):944-9. PubMed ID: 4582438
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum antimycobacterial activity test and chemotherapy of the patients infected with unclassified mycobacteria.
    Nakamura Y
    Dis Chest; 1966 May; 49(5):485-90. PubMed ID: 5935887
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on discharge of atypical myocbacteria in ambulatory patients and treatment of pulmonary disease caused by atypical mycobacteria (so-called atypical mycobacteriosis)].
    Yamaguchi T; Toyohara M
    Kekkaku; 1967 Jul; 42(7):245-50. PubMed ID: 5583607
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental infections caused by atypical mycobacteria. 6. Experimental Mycobacterium fortuitum infection and trial chemotherapy].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1983 Jul; 58(7):385-93. PubMed ID: 6656072
    [No Abstract]   [Full Text] [Related]  

  • 37. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 38. Disseminated Mycobacterium kansasii infection: successful treatment of a patient with pancytopenia.
    Engstrom PF; Dewey GC; Barrett ON
    Am J Med; 1972 Apr; 52(4):533-7. PubMed ID: 5017246
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of antitubercular agents on the development of aseptic inflammation].
    Fedorova VA
    Farmakol Toksikol; 1970; 33(3):346-9. PubMed ID: 5453034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.